FDA warning letter
Closeout letter
Issue date
1 Feb 2019
Issuing office
Dallas District Office
Posted date
5 Mar 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Issue date
7 Sept 2021
Headquarters
Sites
Issue date
Issuing office
Posted date
Subject
Products & Services
Issue date